Endothelial nitric oxide synthase gene polymorphisms in non-arteritic anterior ischemic optic neuropathy

Graefes Arch Clin Exp Ophthalmol. 2007 Feb;245(2):288-92. doi: 10.1007/s00417-005-0245-7.

Abstract

Background: To examine the association between the polymorphisms of the endothelial nitric oxide synthase (eNOS) gene and the occurrence of non-arteritic anterior ischemic optic neuropathy (NAION).

Methods: We studied 15 patients with NAION (mean age, 62 years; 60% male). We investigated two polymorphisms of the eNOS gene, Glu298Asp polymorphism of exon 7 and T(-786)C polymorphism of the promoter region. The genotype distribution in NAION was compared with the control (mean age, 63 years; 63% male) distribution.

Results: There was no significant difference in the genotype distribution of the Glu298Asp polymorphism between the NAION and control groups (P = 1.000), whereas the genotype dis-tribution of the T(-786)C polymorphism varied significantly between the patients with NAION and control subjects (P = 0.002). After adjusting on covariates, individuals with the CC genotype of the T(-786)C polymorphism were more likely to develop NAION compared with those with TT genotype (odds ratio = 0.09: 95% CI 0.01-0.86).

Conclusions: We found an increased prevalence of T(-786)C polymorphism of the eNOS gene in patients with NAION. Our data suggest that the T(-786)C polymorphism of the eNOS gene may be an important risk factor in the development of NAION in Japanese subjects.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Female
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Nitric Oxide Synthase Type III / genetics*
  • Optic Neuropathy, Ischemic / genetics*
  • Polymerase Chain Reaction
  • Polymorphism, Single Nucleotide*

Substances

  • NOS3 protein, human
  • Nitric Oxide Synthase Type III